Universal Biosensors awaits transfusion

The device maker has good upside, but delays are constraining price growth.

To say this is a big year for Universal Biosensors’ chief executive Paul Wright and his team would be an understatement. The medical device maker is either going from “zero to hero” before the year is out, or it will discover how lonely it can be in the doghouse.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles